Obesity is Associated with Shorter Telomere Length in Prostate Stromal Cells in Men with Aggressive Prostate Cancer

This study investigates a potential mechanism underlying the association between obesity and prostate cancer death. Among men with aggressive prostate cancer, obesity was associated with shorter telomeres prostate cancer associated stromal cells, and shorter CAS telomeres have been associated with an increased risk of prostate cancer death. In our prior studies, obesity was associated with shorter telomeres in prostate cancer-associated stromal (CAS) cells, and shorter CAS telomeres were associated with an increased risk of prostate cancer death. To determine whether the association between obesity and shorter CAS telomeres is replicable, we conducted a pooled analysis of 790 men who were surgically treated for prostate cancer, whose tissue samples were arrayed on five tissue microarray (TMA) sets. Telomere signal was measured using a quantitative telomere-specific FISH assay and normalized to 4′,6-diamidino-2-phenylindole for 351 CAS cells (mean) per man; men were assigned their median value. Weight and height at surgery, collected via questionnaire or medical record, were used to calculate body mass index (BMI; kg/m2) and categorize men as normal (<25), overweight (25 ≤ BMI < 30), or obese (≥30). Analyses were stratified by grade and stage. Men were divided into tertiles of TMA- (overall) or TMA- and disease aggressiveness- (stratified) specific distributions; short CAS telomere status was defined by the bottom two tertiles. We used generalized linear mixed models to estimate the association between obesity and short CAS telomeres, adjusting for age, race, TMA set, pathologic stage, and grade. Obesity was not associated with short CAS telomeres overall, or among men with nonaggressive disease. Among men with aggressive disease (Gleason≥4+3 and stage>T2), obese men had a 3-fold increased odds of short CAS telomeres (OR: 3.06; 95% confidence interval: 1.07–8.75; Ptrend = 0.045) when compared with normal weight men. Telomere shortening in prostate stromal cells may be one mechanism through which lifestyle influences lethal prostate carcinogenesis. Prevention Relevance: This study investigates a potential mechanism underlying the association between obesity and prostate cancer death. Among men with aggressive prostate cancer, obesity was associated with shorter telomeres prostate cancer associated stromal cells, and shorter CAS telomeres have been associated with an increased risk of prostate cancer death.

[1]  E. Platz,et al.  Racial Difference in Prostate Cancer Cell Telomere Lengths in Men with Higher Grade Prostate Cancer: A Clue to the Racial Disparity in Prostate Cancer Outcomes , 2020, Cancer Epidemiology, Biomarkers & Prevention.

[2]  L. Egevad,et al.  A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score. , 2016, European urology.

[3]  Stacey A. Kenfield,et al.  Prediagnostic Obesity and Physical Inactivity Are Associated with Shorter Telomere Length in Prostate Stromal Cells , 2015, Cancer Prevention Research.

[4]  S. Manti,et al.  Oxidative Stress in Obesity: A Critical Component in Human Diseases , 2014, International journal of molecular sciences.

[5]  B. Trock,et al.  Obesity and long-term survival after radical prostatectomy. , 2014, The Journal of urology.

[6]  H. Brenner,et al.  Body mass index and leukocyte telomere length in adults: a systematic review and meta‐analysis , 2014, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[7]  Jue Lin,et al.  Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. , 2013, The Lancet. Oncology.

[8]  Stacey A. Kenfield,et al.  Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death. , 2013, Cancer discovery.

[9]  A. Wolk,et al.  Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  A. Benetos,et al.  “Is obesity linked to aging?” Adipose tissue and the role of telomeres , 2012, Ageing Research Reviews.

[11]  A. Partin,et al.  Increased gene copy number of ERG on chromosome 21 but not TMPRSS2–ERG fusion predicts outcome in prostatic adenocarcinomas , 2011, Modern Pathology.

[12]  P. Walsh,et al.  Weight Gain Is Associated with an Increased Risk of Prostate Cancer Recurrence after Prostatectomy in the PSA Era , 2011, Cancer Prevention Research.

[13]  Yin Cao,et al.  Body Mass Index, Prostate Cancer–Specific Mortality, and Biochemical Recurrence: a Systematic Review and Meta-analysis , 2011, Cancer Prevention Research.

[14]  C. Heaphy,et al.  Organ‐wide telomeric status in diseased and disease‐free prostatic tissues , 2010, The Prostate.

[15]  R. O'Sullivan,et al.  Telomeres: protecting chromosomes against genome instability , 2010, Nature Reviews Molecular Cell Biology.

[16]  A. Evans,et al.  Topographical analysis of telomere length and correlation with genomic instability in whole mount prostatectomies. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Wilhelm Palm,et al.  How shelterin protects mammalian telomeres. , 2008, Annual review of genetics.

[18]  W. Gage,et al.  Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining. , 2002, The American journal of pathology.

[19]  J. Campisi,et al.  Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  C B Harley,et al.  Telomere length predicts replicative capacity of human fibroblasts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[21]  B. Trock,et al.  Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men. , 2016, European urology.